10.3 C
London
Sunday, February 23, 2025
HomeMarketsEurope Markets

Europe Markets

spot_img

EMA Open Door Day | European Medicines Agency (EMA)

Event summary As part of the celebrations of...

CoAprovel | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for CoAprovel. It explains how the Committee for Medicinal Products for Human...

Vumerity | European Medicines Agency (EMA)

OverviewVumerity is a medicine used to treat adults with a type of multiple sclerosis (MS) known as relapsing-remitting MS. MS is a disease...

Apidra | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

Lantus | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Lantus. It explains how the Committee for Medicinal Products for Human...

Emtricitabine/Tenofovir disoproxil Krka d.d. | European Medicines Agency (EMA)

OverviewEmtricitabine/Tenofovir disoproxil Krka d.d. is an HIV medicine that is used in combination with at least one other HIV medicine to treat adults...

Rapamune | European Medicines Agency (EMA)

OverviewRapamune is a medicine used to prevent the body from rejecting a newly transplanted kidney. It is used in adults who are at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img